Global Human Growth Hormone Market Report 2024 – Rapid Development of New Novel Recombinant Human Growth Hormones is Forecast to Drive the Market Forward – A $8.73 Billion Forecasted Market by 2028

DUBLIN, March 11, 2024 /PRNewswire/ — The “Global Human Growth Hormone Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis” report has been added to  ResearchAndMarkets.com’s offering.

The Global Human Growth Hormone Market was estimated to be USD 5.74 Billion in 2023 and is expected to reach USD 8.73 Billion by 2028 growing at a CAGR of 8.74%

Key Market Dynamics

Drivers

Surge in the Cases Related to Hormonal Disorders and Hormone Deficiency DisordersIncrease in the Reimbursement Policies

Restraints

High Cost Related to Human Growth Hormone Therapies Procedures

Opportunities

Growing Number of Product Launches of the Human Growth HormoneSurge in Research and Development Fundings from the Private as well as Public Sector

Challenges

Adverse Impact of Human Growth Hormone Therapies on Human Bodies

Market Segmentations

The Global Human Growth Hormone Market is segmented based on Application, Route of Administration, Distribution, and Geography.By Application, the market is classified into Growth Hormone Deficiency, Prader-Willi Syndrome, Turner Syndrome, and Small For Gestational Age (SGA).By Route of Administration, the market is classified into Intramuscular, Intravenous Oral, and Subcutaneous.By Distribution, the market is classified into Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy.By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies’ recent development and competitive scenario. Some of the companies covered in this report are Aeterna Zentaris, Inc., AnkeBio Co., Ltd, Eli Lilly and Company, EMD Serono, Inc. (Merck KGaA), F. Hoffmann-La Roche Ag, Ferring B.V., Genentech, Inc., GeneScience Pharmaceuticals Co., Ltd, Ipsen, etc.

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Human Growth Hormone Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.The publisher analyses the Global Human Growth Hormone Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Report Highlights:

A complete analysis of the market, including parent industryImportant market dynamics and trendsMarket segmentationHistorical, current, and projected size of the market based on value and volumeMarket shares and strategies of key playersRecommendations to companies for strengthening their foothold in the market

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook

4 Market Dynamics
4.1 Drivers
4.1.1 Surge in the Cases Related to Hormonal Disorders and Hormone Deficiency Disorders
4.1.2 Increase in the Reimbursement Policies
4.2 Restraints
4.2.1 High Cost Related to Human Growth Hormone Therapies Procedures
4.3 Opportunities
4.3.1 Growing Number of Product Launches of the Human Growth Hormone
4.3.2 Surge in Research and Development Fundings from the Private as well as Public Sector
4.4 Challenges
4.4.1 Adverse Impact of Human Growth Hormone Therapies on Human Bodies

5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
5.5 PESTLE Analysis

6 Global Human Growth Hormone Market, By Application
6.1 Introduction
6.2 Growth Hormone Deficiency
6.3 Prader-Willi Syndrome
6.4 Turner Syndrome
6.5 Small For Gestational Age (SGA)

7 Global Human Growth Hormone Market, By Route of Administration
7.1 Introduction
7.2 Intramuscular
7.3 Intravenous
7.4 Oral
7.5 Subcutaneous

8 Global Human Growth Hormone Market, By Distribution
8.1 Introduction
8.2 Hospital Pharmacy
8.3 Online Pharmacy
8.4 Retail Pharmacy

9 Americas’ Human Growth Hormone Market

10 Europe’s Human Growth Hormone Market

11 Middle East and Africa’s Human Growth Hormone Market

12 APAC’s Human Growth Hormone Market

13 Competitive Landscape
13.1 Competitive Quadrant
13.2 Market Share Analysis
13.3 Strategic Initiatives
13.3.1 M&A and Investments
13.3.2 Partnerships and Collaborations
13.3.3 Product Developments and Improvements

14 Company Profiles

Aeterna ZentarisAnkeBioEli LillyEMD SeronoF. Hoffmann-La RocheFerringGenentechGeneScience PharmaceuticalsIpsenLG ChemMerckNovartisNovo NordiskPfizerSandoz InternationalShree Venkatesh InternationalSun Pharmaceutical IndustriesTeva Pharmaceutical IndustriesXeris PharmaceuticalsZhongshan Sinobioway Hygene Biomedicine Co., Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/guced6

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/global-human-growth-hormone-market-report-2024—rapid-development-of-new-novel-recombinant-human-growth-hormones-is-forecast-to-drive-the-market-forward—a-8-73-billion-forecasted-market-by-2028–302085604.html

SOURCE Research and Markets